Your browser doesn't support javascript.
loading
Repurposing GLP1 agonists for neurodegenerative diseases.
Markaki, Ioanna; Winther, Kristian; Catrina, Sergiu-Bogdan; Svenningsson, Per.
Afiliación
  • Markaki I; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center of Neurology, Academic Specialist Center, Stockholm, Sweden. Electronic address: ioanna.markaki@ki.se.
  • Winther K; Center of Diabetes, Academic Specialist Center, Stockholm, Sweden.
  • Catrina SB; Center of Diabetes, Academic Specialist Center, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Svenningsson P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center of Neurology, Academic Specialist Center, Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden. Electronic address: per.svenningsson@ki.se.
Int Rev Neurobiol ; 155: 91-112, 2020.
Article en En | MEDLINE | ID: mdl-32854860
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Enfermedades Neurodegenerativas / Péptido 1 Similar al Glucagón / Reposicionamiento de Medicamentos / Hipoglucemiantes Tipo de estudio: Etiology_studies Idioma: En Revista: Int Rev Neurobiol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Enfermedades Neurodegenerativas / Péptido 1 Similar al Glucagón / Reposicionamiento de Medicamentos / Hipoglucemiantes Tipo de estudio: Etiology_studies Idioma: En Revista: Int Rev Neurobiol Año: 2020 Tipo del documento: Article